Which Biotechs Enjoyed A 'JPM Jump' - And Which Lost Out?

As participants from this year’s J.P. Morgan Healthcare conference recover from the torrent of new information they were exposed to, Scrip explores which biotechs saw a sustainable shift in their valuations.